Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii

Frontiers in Microbiology

Volumn 7, Issue APR, 2016, Pages

  Qi, Lihua ^a   Li, Hao ^a   Zhang, Chuanfu ^a   Liang, Beibei ^a   Li, Jie ^a   Wang, Ligui ^a   Du, Xinying ^a   Liu, Xuelin ^a   Qiu, Shaofu ^a   Song, Hongbin ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Biofilm; Biofilm specific resistance; Pulsed field gel electrophoresis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHEM DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MEZLOCILLIN; MINOCYCLINE; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; SULTAMICILLIN; TETRACYCLINE DERIVATIVE; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; BROTH DILUTION; DISK DIFFUSION; GENETIC SIMILARITY; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS;

EID: 84966312152     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00483     Document Type: Article

References (34)

1. Abidi, S. H., Sherwani, S. K., Siddiqui, T. R., Bashir, A., and Kazmi, S. U. (2013). Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan. BMC Ophthalmol. 13:57. doi: 10.1186/1471-2415-13-57.
2. Andersson, D. I., and Hughes, D. (2010). Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8, 260-271. doi: 10.1038/nrmicro2319.
3. Atashili, J., Lyonga, E. E., Mandi, H., Ikomey, G., Mukwele, B., and Eyoh, A. B. (2014). Relationship between multiple drug resistance and biofilm formation in Staphylococcus aureus isolated from medical and non-medical personnel in Yaoundé, Cameroon. Pan Afr. Med. J. 17:186. doi: 10.11604/pamj.2014.17.186.2363.
4. Bergogne-Bérézin, E., and Towner, K. J. (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9, 148-165.
5. Ceri, H., Olson, M., Morck, D., Storey, D., Read, R., Buret, A., et al. (2001). The MBEC assay system: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol. 337, 377-385. doi: 10.1016/S0076-6879(01)37026-X.
6. Cernohorská, L., and Votava, M. (2004). Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria. Folia Microbiol (Praha) 49, 75-78. doi: 10.1007/BF02931650.
7. Cerqueira, G. M., and Peleg, A. Y. (2011). Insights into Acinetobacter baumannii pathogenicity. IUBMB Life 63, 1055-1060. doi: 10.1002/iub.533.
8. CLSI (2015). "Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement, " in CLSI document M100-S25, (Wayne, PA: Clinical and Laboratory Standards Institute).
9. Gallant, C. V., Daniels, C., Leung, J. M., Ghosh, A. S., Young, K. D., Kotra, L. P., et al. (2005). Common beta-lactamases inhibit bacterial biofilm formation. Mol. Microbiol. 58, 1012-1024. doi: 10.1111/j.1365-2958.2005.04892.x.
10. Gurung, J., Khyriem, A. B., Banik, A., Lyngdoh, W. V., Choudhury, B., and Bhattacharyya, P. (2013). Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J. Crit. Care Med. 17, 214-218. doi: 10.4103/0972-5229.
11. Hall-Stoodley, L., Costerton, J. W., and Stoodley, P. (2004). Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95-108. doi: 10.1038/nrmicro821.
12. Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., and Miller, S. I. (2005). Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436, 1171-1175. doi: 10.1038/nature03912.
13. Hoyle, B. D., and Costerton, J. W. (1991). Bacterial resistance to antibiotics: the role of biofilms. Prog. Drug Res. 37, 91-105.
14. Hung, K. H., Wang, M. C., Huang, A. H., Yan, J. J., and Wu, J. J. (2012). Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii. J. Clin. Microbiol. 50, 721-726. doi: 10.1128/JCM.05085-11.
15. Kaplan, J. B. (2011). Antibiotic-induced biofilm formation. Int. J. Artif. Organs 34, 737-751. doi: 10.5301/ijao.5000027.
16. Karch, H., Heesemann, J., Laufs, R., O'Brien, A. D., Tacket, C. O., and Levine, M. M. (1987). A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun. 55, 455-461.
17. Lee, H. W., Koh, Y. M., Kim, J., Lee, J. C., Lee, Y. C., Seol, S. Y., et al. (2008). Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 14, 49-54. doi: 10.1111/j.1469-0691.2007.01842.x.
18. Levin, B. R., and Rozen, D. E. (2006). Non-inherited antibiotic resistance. Nat. Rev. Microbiol. 4, 556-562. doi: 10.1038/nrmicro1445.
19. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., et al. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268-281. doi: 10.1111/j.1469-0691.2011.03570.x.
20. Mah, T. F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., and O'Toole, G. A. (2003). A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426, 306-310. doi: 10.1038/nature02122.
21. McDougald, D., Rice, S. A., Barraud, N., Steinberg, P. D., and Kjelleberg, S. (2012). Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat. Rev. Microbiol. 10, 39-50. doi: 10.1038/nrmicro2695.
22. Mendoza-Olazaran, S., Camacho-Ortiz, A., Martínez-Reséndez, M. F., Llaca-Díaz, J. M., Perez-Rodriguez, E., and Garza-Gonzalez, E. (2014). Influence of whole-body washing of critically ill patients with chlorhexidine on Acinetobacter baumannii isolates. Am. J. Infect. Control 42, 874-878. doi: 10.1016/j.ajic.2014.04.009.
23. O'Neill, E., Pozzi, C., Houston, P., Humphreys, H., Robinson, D. A., Loughman, A., et al. (2008). A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J. Bacteriol. 190, 3835-3850. doi: 10.1128/JB.00167-08.
24. O'Toole, G. A. (2011). Microtiter dish biofilm formation assay. J. Vis. Exp. 47:e2437. doi: 10.3791/2437.
25. Perez, F., Endimiani, A., and Bonomo, R. A. (2008). Why are we afraid of Acinetobacter baumannii? Expert Rev. Anti Infect. Ther. 6, 269-271. doi: 10.1586/14787210.6.3.269.
26. Perez, L. R. (2015). Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production. J. Chemother. 27, 13-16. doi: 10.1179/1973947813Y.0000000159.
27. Rodríguez-Baño, J., Martí, S., Soto, S., Fernández-Cuenca, F., Cisneros, J. M., Pachón, J., et al. (2008). Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin. Microbiol. Infect. 14, 276-278. doi: 10.1111/j.1469-0691.2007.01916.x.
28. Seifert, H., Dolzani, L., Bressan, R., van der Reijden, T., van Strijen, B., Stefanik, D., et al. (2005). Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol. 43, 4328-4335. doi: 10.1128/JCM.43.9.4328-4335.2005.
29. Sherley, M., Gordon, D. M., and Collignon, P. J. (2004). Evolution of multi-resistance plasmids in Australian clinical isolates of Escherichia coli. Microbiology150, 1539-1546. doi: 10.1099/mic.0.26773-0.
30. Singhai, M., Malik, A., Shahid, M., Malik, M. A., and Goyal, R. (2012). A study on device-related infections with special reference to biofilm production and antibiotic resistance. J. Glob. Infect. Dis. 4, 193-198. doi: 10.4103/0974-777X.103896.
31. Spoering, A. L., and Lewis, K. (2001). Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183, 6746-6751. doi: 10.1128/JB.183.23.6746-6751.2001.
32. Talbot, G. H., Bradley, J., Edwards, J. E. Jr., Gilbert, D., Scheld, M., Bartlett, J. G., et al. (2006). Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases Society of America. Clin. Infect. Dis. 42, 657-668. doi: 10.1086/499819.
33. Wang, H., Guo, P., Sun, H., Wang, H., Yang, Q., Chen, M., et al. (2007). Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother. 51, 4022-4028. doi: 10.1128/AAC.01259-06.
34. Zhang, L., Fritsch, M., Hammond, L., Landreville, R., Slatculescu, C., Colavita, A., et al. (2013). Identification of genes involved in Pseudomonas aeruginosa biofilm-specific resistance to antibiotics. PLoS ONE 8:e61625. doi: 10.1371/journal.pone.0061625.